eHow launches Android app: Get the best of eHow on the go.
Summary: Experimental breast cancer treatments include hormonal therapies that eliminate or counteract estrogen, and other treatments involve the use of monoclonal antibodies. Learn about PARP inhibitors as a part of experimental breast cancer treatments with information from an oncologist in this free video on treatments for breast cancer.
Dr. Grace Wang, M.D., is an oncologist and hematologist for Advanced Medical Specialties, who works closely with The Susan G. Komen Breast Cancer Foundation, in Miami, Fla. Dr. Wang is...read more
"Hi, I'm Dr. Grace Wang. I'm a Medical Oncologist working at Advanced Medical Specialties in Miami, Florida. I'm here on the behalf of The Susan G. Komen Foundation. Let's talk about experimental treatments for breast cancer exceeding signing time in research for breast cancer. We've always had different hormonal therapies that eliminate estrogen or counteract estrogen; but we also have experimental treatments such as monoclonal antibodies. We have Herceptin which is a monoclonal antibody to the hurt to new, antigen; however if there are other monoclonal antibodies that we're doing more research with such as Avastin which is just been approved for treatment for metastatic breast cancer. We're now experimenting it with adjuvant treatments. So right after breast cancer patients surgery, we have trials that insert Avastin as part of the treatment. We have new Tyrosine Kinase inhibitors that are working inside the cell that work against different processes of growth. We have also PARP inhibitors that are different pathways and other new molecules that are, we're testing the effectiveness in different types of breast cancer."
eHow Article: Experimental Treatments of Breast Cancer